References of "Evrard, Brigitte"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailTowards a real time release approach for manufacturing tablets using NIR spectroscopy
Pestieau, Aude ULiege; Krier, Fabrice ULiege; Thoorens, Grégory et al

in Journal of Pharmaceutical & Biomedical Analysis (2014), 98

Detailed reference viewed: 69 (24 ULiège)
See detailPolyplexes Targeting Angiogenesis in Cancer
Frère, Antoine ULiege; Peixoto, Paul ULiege; Kawalec, Michal et al

Poster (2014, April)

Detailed reference viewed: 35 (5 ULiège)
Full Text
Peer Reviewed
See detailZelfbehandeling van frequente hoofdpijn : een Belgische apotheekstudie
Mehuys, E; Paemeleire, K; Van Hees, Thierry ULiege et al

Conference (2014)

Detailed reference viewed: 36 (8 ULiège)
Full Text
Peer Reviewed
See detailDevice-based controlled local delivery of anastrozol into peritoneal cavity: in vitro and in vivo evaluation
Krier, Fabrice ULiege; Riva, Raphaël ULiege; Defrère, Sylvie et al

in Journal of Drug Delivery Science and Technology [=JDDST] (2014), 24(2), 198-204

Local treatment using drug loaded implants allows decreasing seric concentrations of the active ingredient with the purpose of limiting side effects and reaching perfect observance. Nowadays, some ... [more ▼]

Local treatment using drug loaded implants allows decreasing seric concentrations of the active ingredient with the purpose of limiting side effects and reaching perfect observance. Nowadays, some diseases are already treated with implants, but generally, by subcutaneous or intra vaginal implantation. In this work, a new implant device dedicated to the intra-peritoneal cavity was developed. For this purpose, a core-membrane polymer implant was selected. We propose an original method to determine the most appropriate membrane to control the release based on the use of Franz cells. The ability of the implant to release a constant quantity of an active ingredient will be assessed by testing implants in vitro. Finally, intra peritoneal cavity and subcutaneous in vivo implantation has been achieved in order to confirm the controlled and local release of the active ingredient. [less ▲]

Detailed reference viewed: 101 (13 ULiège)
Full Text
See detailPolyplex Based On Polycarbonate Polymers For An Efficient Delivery Of An Anti-Angiogenic siRNA
Frère, Antoine ULiege; Kawalec, Michal; Tempelaar, Sarah et al

Poster (2014)

Detailed reference viewed: 18 (7 ULiège)
Full Text
See detailDevelopment of anti-HPV lipoplexes for the treatment of cervical cancer
Lechanteur, Anna ULiege; Furst, Tania ULiege; Evrard, Brigitte ULiege et al

Conference (2013, December 03)

Detailed reference viewed: 19 (8 ULiège)
See detailThe intracellular fate of polycarbonate Polyplexes modulates the efficacy of siRNA
Frère, Antoine ULiege; Kawalec, Michal; Peixoto, Paul ULiege et al

Poster (2013, December)

Detailed reference viewed: 23 (5 ULiège)
Full Text
Peer Reviewed
See detailReal time release approach in terms of four Pharmacopoeia tests for tablets manufacturing using NIR spectroscopy
Pestieau, Aude ULiege; Krier, Fabrice ULiege; Thoorens, Grégory et al

Poster (2013, November)

Detailed reference viewed: 19 (4 ULiège)